T-Rex 2X Inverse MSTR Daily Target ETF vs Raytheon Technologies Corp — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.59 (market cap $94.46M), while Raytheon Technologies Corp trades at $185.77 (market cap $248.42B). The key difference: Raytheon Technologies Corp is far larger — about 2629.9× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Raytheon Technologies Corp pays a 1.58% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days and Raytheon Technologies Corp for 77 Days on average.
| MSTZ | RTX | |
|---|---|---|
Market Cap | $94.46M | $248.42B |
Volume | 104,717,733 | 4,380,368 |
Sector | Leveraged / Inverse | Industrials |
52-Week High | $27.92 | $225.49 |
52-Week Low | $2.29 | $157.00 |
Typical Hold Time | 8 Days | 77 Days |
Enterprise Value | — | $278.97B |
Dividend Yield | — | 1.58% |
Signals from Pluang's Aura AI — not financial advice
MSTZ is trading at $2.54, down 4.51% today, with technical indicators showing a bearish trend as moving averages signal selling pressure. The stock lacks key financial ratio data, making fundamental assessment challenging. Recent ETF coverage highlights its inclusion in leveraged/inverse ETF discussions, though specific company performance details are limited.
The outlook remains cautious due to incomplete financial disclosures and bearish technical signals. Investment opportunities depend on forthcoming earnings clarity, while risks include volatility from limited institutional coverage and market sentiment shifts. Investors should await detailed financial updates for informed decisions.
RTX trades at $180.26, down 1.65% today, amid a bearish technical signal but strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q3 2026 EPS expected at $1.77. Revenue grew to $88.6B in 2025, with net income margin improving to 7.59%. Analyst consensus remains strongly bullish with a $236.27 price target and 65% buy ratings, supported by a $289B backlog and defense sector tailwinds.
The outlook for RTX is positive given robust defense spending, earnings momentum, and analyst confidence. Risks include execution on large contracts, debt levels, and geopolitical uncertainties. The stock offers growth potential with a 30% upside to consensus target, but investors should monitor quarterly execution and defense budget developments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →